Holen Sie sich die Stockscreener-App
1.45
6.62%
0.09
Handel nachbörslich:
1.42
-0.03
-2.07%
Schlusskurs vom Vortag:
$1.36
Offen:
$1.485
24-Stunden-Volumen:
1.01M
Relative Volume:
0.57
Marktkapitalisierung:
$550.74M
Einnahmen:
$106.34M
Nettoeinkommen (Verlust:
$-74.66M
KGV:
-1.5263
EPS:
-0.95
Netto-Cashflow:
$-46.12M
1W Leistung:
+16.94%
1M Leistung:
+17.89%
6M Leistung:
-12.39%
1J Leistung:
-36.12%
1-Tages-Spanne:
$1.435
$1.49
1-Wochen-Bereich:
$1.20
$1.49
52-Wochen-Spanne:
$0.92
$2.41
Standard Biotools Inc Stock (LAB) Company Profile
Firmenname
Standard Biotools Inc
Sektor
Branche
Telefon
(650) 266-6000
Adresse
2 TOWER PLACE, SOUTH SAN FRANCISCO
Vergleichen Sie LAB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LAB
Standard Biotools Inc
|
1.45 | 491.29M | 106.34M | -74.66M | -46.12M | -0.95 |
|
ABT
Abbott Laboratories
|
125.83 | 218.75B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
107.76 | 152.62B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
400.93 | 151.01B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
92.01 | 117.43B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.91 | 44.76B | 5.54B | 4.18B | 623.10M | 7.00 |
Standard Biotools Inc Stock (LAB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-27 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-04-16 | Eingeleitet | TD Cowen | Buy |
| 2024-04-04 | Eingeleitet | Jefferies | Buy |
| 2023-07-12 | Eingeleitet | KeyBanc Capital Markets | Overweight |
Standard Biotools Inc Aktie (LAB) Neueste Nachrichten
Is Standard BioTools Inc. a good long term investmentFree Stock Market Real-Time Monitoring - Autocar Professional
Standard BioTools Inc. Stock Analysis and ForecastFree Wealth Planning Blueprint - Autocar Professional
What analysts say about Standard BioTools Inc. stockFree Risk Assessment Services - jammulinksnews.com
What drives Standard BioTools Inc. stock priceTriple returns potential - Autocar Professional
Published on: 2025-07-22 13:31:08 - jammulinksnews.com
32,647 Shares in Standard BioTools Inc. (NASDAQ:LAB) Bought by Teacher Retirement System of Texas - Defense World
Standard BioTools Schedules Second Quarter Earnings Conference Call on August 11, 2025 - GlobeNewswire
Standard BioTools to report Q2 2025 financial results on August 11. - AInvest
Standard BioTools Sets Key Q2 Earnings Date: Here's When and How to Listen - Stock Titan
how standard biotools inc. stock performs during market volatilityFree Predictions - Newser
What makes Standard BioTools Inc. stock price move sharplyFree Investment Group - Newser
Why Standard BioTools Inc. stock attracts strong analyst attentionReturn Optimized Trade Insights - Newser
How Standard BioTools Inc. stock performs during market volatilityFree Professional Trading Signals - Newser
Standard BioTools Inc.'s (NASDAQ:LAB) P/S Is Still On The Mark Following 26% Share Price Bounce - simplywall.st
Standard BioTools jumps on sale of SomaLogic to Illumina - MSN
Illumina to Acquire SomaLogic for $350 Million, Expanding into Proteomics and Precision Medicine - MSN
Illumina Expands into Proteomics with $350 Million Acquisition of SomaLogic - AInvest
Illumina Stock May Benefit From New Agreement to Acquire SomaLogic - TradingView
Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy - PR Newswire
Standard BioTools stock soars after selling SomaLogic to Illumina for $425M - Investing.com UK
Standard BioTools (LAB) Soars on SomaLogic Sale to Illumina for $425M - GuruFocus
Illumina to acquire SomaLogic for $350 million in proteomics expansion - Investing.com
With 48% stake, Standard BioTools Inc. (NASDAQ:LAB) seems to have captured institutional investors' interest - Yahoo
Deeper Dive: Understanding Standard BioTools Inc (LAB) Through its Various Ratios - DWinneX
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Raises Stock Holdings in Standard BioTools Inc. (NASDAQ:LAB) - MarketBeat
Standard BioTools Inc. (NASDAQ:LAB) Shares Bought by Bank of America Corp DE - Defense World
Finanzdaten der Standard Biotools Inc-Aktie (LAB)
Umsatz
Nettogewinn
Free Cashflow
ENV
Standard Biotools Inc-Aktie (LAB) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Mackay Sean | SVP & Chief Business Officer |
May 23 '25 |
Sale |
0.94 |
13,217 |
12,437 |
843,076 |
| Egholm Michael | President & CEO |
May 23 '25 |
Sale |
0.94 |
5,473 |
5,150 |
2,741,191 |
| Kim Hanjoon Alex | Chief Financial Officer |
May 22 '25 |
Sale |
1.00 |
1,355 |
1,358 |
931,714 |
| Egholm Michael | President & CEO |
May 22 '25 |
Sale |
1.00 |
5,116 |
5,126 |
2,746,664 |
| Mackay Sean | SVP & Chief Business Officer |
May 21 '25 |
Sale |
1.03 |
12,838 |
13,223 |
868,829 |
| Mackay Sean | SVP & Chief Business Officer |
May 22 '25 |
Sale |
1.00 |
12,536 |
12,561 |
856,293 |
0.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):